⌘K

Home/Filings/4/0001493152-20-023466

4//SEC Filing

Huntsman Ronald Kirk 4

Accession 0001493152-20-023466

CIK 0001716166other

View on SEC.gov Company Profile

Filed

Dec 13, 7:00 PM ET

Accepted

Dec 14, 8:45 AM ET

Size

6.8 KB

Accession

0001493152-20-023466

Insider Transaction Report

Form 4

Period: 2020-12-11

Vivos Therapeutics, Inc.VVOS

Huntsman Ronald Kirk

DirectorChief Executive Officer10% Owner

Transactions

Purchase
Common Stock
2020-12-11$8.50/sh+500$4,250→ 500 total

Holdings

Stock Option
Exercise: $1.65Exp: 2022-09-30→ Common Stock (333,334 underlying)
333,334
Common Stock
(indirect: See Footnote)
1,749,000

Footnotes (2)

[F1]Shares held by Coronado V Partners, LLC, of which the reporting person is a member and manager.
[F2]The option is fully vested and exercisable.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Vivos Therapeutics, Inc.

CIK 0001716166

Entity typeother

Related Parties

1

filerCIK 0001835498

Filing Metadata

Form type: 4
Filed: Dec 13, 7:00 PM ET
Accepted: Dec 14, 8:45 AM ET
Size: 6.8 KB

View on SEC.gov